Chemed Co. (NYSE:CHE) CEO Sells $1,187,340.00 in Stock

Chemed Co. (NYSE:CHE - Get Free Report) CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Chemed Price Performance

Shares of CHE stock traded up $1.51 during trading hours on Friday, reaching $595.86. 124,996 shares of the company traded hands, compared to its average volume of 99,602. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62. The company has a market cap of $8.72 billion, a P/E ratio of 30.11, a P/E/G ratio of 2.15 and a beta of 0.43. The firm has a 50-day moving average price of $553.87 and a 200 day moving average price of $564.10.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. Chemed's payout ratio is currently 10.05%.

Remove Ads

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. HighTower Advisors LLC lifted its holdings in Chemed by 78.0% in the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock worth $2,246,000 after purchasing an additional 1,634 shares in the last quarter. XTX Topco Ltd lifted its holdings in Chemed by 111.5% in the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company's stock worth $1,709,000 after purchasing an additional 1,499 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock worth $201,820,000 after purchasing an additional 15,791 shares in the last quarter. Signal Advisors Wealth LLC lifted its holdings in Chemed by 60.7% in the 4th quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company's stock worth $2,647,000 after purchasing an additional 1,886 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Chemed by 8.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company's stock worth $73,792,000 after purchasing an additional 9,178 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.